Status:
WITHDRAWN
Infections of the Central Nervous System
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Adult Patients With Suspected Meningitis and/or Encephalitis
Eligibility:
All Genders
18+ years
Brief Summary
This study is to describe the incidence of infectious meningitis and/or encephalitis, and to analyze clinical, diagnostic and treatment characteristics of patients with suspected (and subsequently ver...
Detailed Description
The specific aims of the study include: 1. To assess the incidence, the diagnostic workup, and the treatment characteristics of patients with suspected and confirmed ME. 2. To examine clinical differ...
Eligibility Criteria
Inclusion
- All patients aged ≥18 years admitted to the University Hospital Basel with confirmed infectious meningitis and/or encephalitis as principal and/or secondary diagnosis from January 2006 to December 2021 with or without cranial CT prior to LP
- All patients aged ≥18 years admitted to the University Hospital Basel over the same time period with suspected infectious meningitis and/or encephalitis as principal and/or secondary diagnosis with or without cranial CT
Exclusion
- Patients without suspected infectious meningitis and/or encephalitis.
- Patients with the diagnosis of meningitis/encephalitis confirmed prior to hospital admission
- Patients who have refused "General Consent" (i.e., written agreement of patients which allows the further use of their collected medical data for research purposes in encoded form).
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03856528
Start Date
March 1 2019
End Date
December 31 2024
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Intensive Care Medicine, University Hospital Basel
Basel, Switzerland, 4031